These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 18052968

  • 1. Enumeration of haemagglutinin-specific CD8+ T cells after influenza vaccination using MHC class I peptide tetramers.
    Kosor Krnic E, Gagro A, Drazenovic V, Kuzman I, Jeren T, Cecuk-Jelicic E, Kerhin-Brkljacic V, Gjenero-Margan I, Kaic B, Rakusic S, Sabioncello A, Markotic A, Rabatic S, Mlinaric-Galinovic G, Dekaris D.
    Scand J Immunol; 2008 Jan; 67(1):86-94. PubMed ID: 18052968
    [Abstract] [Full Text] [Related]

  • 2. Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination.
    Zinckgraf JW, Sposato M, Zielinski V, Powell D, Treanor JJ, von Hofe E.
    Vaccine; 2009 Aug 27; 27(39):5393-401. PubMed ID: 19596415
    [Abstract] [Full Text] [Related]

  • 3. E-rosette forming cells and humoral antibody titres in humans after vaccination with three different inactivated influenza virus vaccines A/USSR/92/77 (H1N1).
    Schmidt S, Süss J, Oehring H, Schmidt J.
    Acta Virol; 1982 Dec 27; 26(6):466-73. PubMed ID: 6132540
    [Abstract] [Full Text] [Related]

  • 4. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.
    Tao P, Luo M, Pan R, Ling D, Zhou S, Tien P, Pan Z.
    Antiviral Res; 2009 Mar 27; 81(3):253-60. PubMed ID: 19135483
    [Abstract] [Full Text] [Related]

  • 5. Cell-mediated immune responses to influenza vaccination in healthy volunteers and allogeneic stem cell transplant recipients.
    Avetisyan G, Ragnavölgyi E, Toth GT, Hassan M, Ljungman P.
    Bone Marrow Transplant; 2005 Sep 27; 36(5):411-5. PubMed ID: 15980884
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of immune responses to seasonal influenza vaccination in healthy volunteers and in patients after stem cell transplantation.
    Avetisyan G, Aschan J, Hassan M, Ljungman P.
    Transplantation; 2008 Jul 27; 86(2):257-63. PubMed ID: 18645488
    [Abstract] [Full Text] [Related]

  • 7. Cell-mediated immune responses to influenza vaccination in Wegener's granulomatosis.
    Holvast A, de Haan A, van Assen S, Stegeman CA, Huitema MG, Huckriede A, Benne CA, Westra J, Palache A, Wilschut J, Kallenberg CG, Bijl M.
    Ann Rheum Dis; 2010 May 27; 69(5):924-7. PubMed ID: 19596692
    [Abstract] [Full Text] [Related]

  • 8. Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus.
    Holvast A, van Assen S, de Haan A, Huckriede A, Benne CA, Westra J, Palache A, Wilschut J, Kallenberg CG, Bijl M.
    Arthritis Rheum; 2009 Aug 27; 60(8):2438-47. PubMed ID: 19644961
    [Abstract] [Full Text] [Related]

  • 9. Abortive activation precedes functional deletion of CD8+ T cells following encounter with self-antigens expressed by resting B cells in vivo.
    Fraser JM, Janicki CN, Raveney BJ, Morgan DJ.
    Immunology; 2006 Sep 27; 119(1):126-33. PubMed ID: 16796693
    [Abstract] [Full Text] [Related]

  • 10. Identification of immunogenic consensus T-cell epitopes in globally distributed influenza-A H1N1 neuraminidase.
    Gupta SK, Srivastava M, Akhoon BA, Smita S, Schmitz U, Wolkenhauer O, Vera J, Gupta SK.
    Infect Genet Evol; 2011 Mar 27; 11(2):308-19. PubMed ID: 21094280
    [Abstract] [Full Text] [Related]

  • 11. Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity.
    Okamoto S, Yoshii H, Akagi T, Akashi M, Ishikawa T, Okuno Y, Takahashi M, Yamanishi K, Mori Y.
    Vaccine; 2007 Nov 28; 25(49):8270-8. PubMed ID: 17977633
    [Abstract] [Full Text] [Related]

  • 12. Peptide-loaded chimeric influenza virosomes for efficient in vivo induction of cytotoxic T cells.
    Amacker M, Engler O, Kammer AR, Vadrucci S, Oberholzer D, Cerny A, Zurbriggen R.
    Int Immunol; 2005 Jun 28; 17(6):695-704. PubMed ID: 15843436
    [Abstract] [Full Text] [Related]

  • 13. Phenotypic changes in influenza-specific CD8+ T cells after immunization of children and adults with influenza vaccines.
    He XS, Holmes TH, Mahmood K, Kemble GW, Dekker CL, Arvin AM, Greenberg HB.
    J Infect Dis; 2008 Mar 15; 197(6):803-11. PubMed ID: 18279048
    [Abstract] [Full Text] [Related]

  • 14. Analysis of the frequencies and of the memory T cell phenotypes of human CD8+ T cells specific for influenza A viruses.
    He XS, Mahmood K, Maecker HT, Holmes TH, Kemble GW, Arvin AM, Greenberg HB.
    J Infect Dis; 2003 Apr 01; 187(7):1075-84. PubMed ID: 12660922
    [Abstract] [Full Text] [Related]

  • 15. Increasing doses of an inactivated influenza A/H1N1 vaccine induce increasing levels of cross-reacting antibody to subsequent, antigenically different, variants.
    Keitel WA, Atmar RL, Nino D, Cate TR, Couch RB.
    J Infect Dis; 2008 Oct 01; 198(7):1016-8. PubMed ID: 18729777
    [Abstract] [Full Text] [Related]

  • 16. Lipid-containing mimetics of natural triggers of innate immunity as CTL-inducing influenza vaccines.
    Lau YF, Deliyannis G, Zeng W, Mansell A, Jackson DC, Brown LE.
    Int Immunol; 2006 Dec 01; 18(12):1801-13. PubMed ID: 17077175
    [Abstract] [Full Text] [Related]

  • 17. Functional and phenotypic characterization of peptide-vaccine-induced HCV-specific CD8+ T cells in healthy individuals and chronic hepatitis C patients.
    Schlaphoff V, Klade CS, Jilma B, Jelovcan SB, Cornberg M, Tauber E, Manns MP, Wedemeyer H, IC41 Study Group.
    Vaccine; 2007 Sep 17; 25(37-38):6793-806. PubMed ID: 17686555
    [Abstract] [Full Text] [Related]

  • 18. A comparison of the humoral and cellular immune responses at different immunological sites after split influenza virus vaccination of mice.
    Hauge S, Madhun AS, Cox RJ, Brokstad KA, Haaheim LR.
    Scand J Immunol; 2007 Jan 17; 65(1):14-21. PubMed ID: 17212762
    [Abstract] [Full Text] [Related]

  • 19. Sindbis virus vectors elicit hemagglutinin-specific humoral and cellular immune responses and offer a dose-sparing strategy for vaccination.
    Miller A, Center RJ, Stambas J, Deliyannis G, Doherty PC, Howard JL, Turner SJ, Purcell DF.
    Vaccine; 2008 Oct 16; 26(44):5641-8. PubMed ID: 18761047
    [Abstract] [Full Text] [Related]

  • 20. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP, Veits J, Keil GM, Mettenleiter TC, Fuchs W.
    Vaccine; 2009 Jan 29; 27(5):773-85. PubMed ID: 19041677
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.